Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

Lamb, C. A.; Sebastian, S.; Kent, A. J.; Segal, J. P.; Gonzalez, H. A.; Brookes, M. J.; Mehta, S. J.; Subramanian, S.; Bhala, N.; Hicks, L. C.; Conley, T. E.; Patel, K. V.; Walker, G. J.; Kennedy, N. A.; Grp, Prepare-Ibd Study

Lamb, C. A.; Sebastian, S.; Kent, A. J.; Segal, J. P.; Gonzalez, H. A.; Brookes, M. J.; Mehta, S. J.; Subramanian, S.; Bhala, N.; Hicks, L. C.; Conley, T. E.; Patel, K. V.; Walker, G. J.; Kennedy, N. A.; Grp, Prepare-Ibd Study.

Journal of Crohns & Colitis ; 15:S409-S410, 2021.

Article in English | Web of Science | ID: covidwho-1510931

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Web of Science Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Journal of Crohns & Colitis Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google